Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver

• Published in: Journal of physiology and biochemistry Vol. 57; no. 1; pp. 1 - 8
• Main Authors: Bonilla, S, Redonnet, A, Noël-Suberville, C, Groubet, R, Pallet, V, Higueret, P
• Format: Journal Article
• Language: English
• Published: Spain 01.03.2001
• Subjects: Acyl-CoA Oxidase; Animals; Bezafibrate - pharmacology; Gene Expression - drug effects; Kinetics; Liver - drug effects; Liver - metabolism; Male; Oxidoreductases - genetics; Peroxisome Proliferators - pharmacology; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear - genetics; Receptors, Cytoplasmic and Nuclear - metabolism; Receptors, Retinoic Acid - genetics; Receptors, Retinoic Acid - metabolism; Receptors, Thyroid Hormone - genetics; Receptors, Thyroid Hormone - metabolism; RNA, Messenger - genetics; RNA, Messenger - metabolism; Transcription Factors - genetics; Transcription Factors - metabolism
• ISSN: 1138-7548; 1877-8755
• DOI: 10.1007/bf03179807

It has recently been shown that high-fat diets induce the expression of peroxisome proliferator-activated receptor (PPAR) with a concomitant decrease in expression of retinoic acid (RAR) and triiodothyronine (TR) receptors in rat liver. The authors have suggested that PPAR activation may be responsible for these modifications in nuclear receptor expression. With the aim of gaining further insight into a possible relationship between the patterns of expression of these receptors, we have examined, using a pharmacological model, the effect of a strong and specific PPAR activation induced by bezafibrate, a peroxisome proliferator agent. Activation of PPAR was evaluated by quantifying PPAR alpha mRNA and acyl-CoA oxidase mRNA. The expression of RAR and TR was determined by assaying the binding properties of these nuclear receptors and by quantifying the mRNA level of RAR beta and TR alpha1,beta1 isoforms. After a 10 day treatment of young rats, induction of PPAR (PPAR alpha mRNA was increased by 40% [P< 0.05 and acyl-CoA oxidase mRNA by 411% [P<0.001]) and a concomitant decrease of RAR and TR expression (Maximal Binding Capacity was decreased by 21 and 26%, respectively [P<0.05]) in the liver was observed. RXR alpha mRNA expression was unchanged by treatment. Cross-talk between RAR, TR and PPAR signalling pathways may be implicated in the new patterns of nuclear receptor expression observed. The decreased expression of RAR and TR reported here could provide a novel element for the understanding of the link between PPAR and tumorigenesis in rat liver.